Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Patient-reported outcomes in polymyalgia rheumatica.

Matteson EL, Maradit-Kremers H, Cimmino MA, Schmidt WA, Schirmer M, Salvarani C, Bachta A, Dejaco C, Duftner C, Slott Jensen H, Poór G, Kaposi NP, Mandl P, Balint PV, Schmidt Z, Iagnocco A, Cantini F, Nannini C, Macchioni P, Pipitone N, Del Amo M, Espígol-Frigolé G, Cid MC, Martínez-Taboada VM, Nordborg E, Direskeneli H, Aydin SZ, Ahmed K, Hazelman B, Pease C, Wakefield RJ, Luqmani R, Abril A, Marcus R, Gonter NJ, Maz M, Crowson CS, Dasgupta B.

J Rheumatol. 2012 Apr;39(4):795-803. doi: 10.3899/jrheum.110977. Epub 2012 Mar 15.

2.

Plasma fibrinogen along with patient-reported outcome measures enhances management of polymyalgia rheumatica: a prospective study.

McCarthy EM, MacMullan PA, Al-Mudhaffer S, Madigan A, Donnelly S, McCarthy CJ, Molloy ES, Kenny D, McCarthy GM.

J Rheumatol. 2014 May;41(5):931-7. doi: 10.3899/jrheum.131055. Epub 2014 Apr 1.

PMID:
24692520
3.

Ultrasonographic monitoring of response to therapy in polymyalgia rheumatica.

Jiménez-Palop M, Naredo E, Humbrado L, Medina J, Uson J, Francisco F, García-Yebenes MJ, Garrido J.

Ann Rheum Dis. 2010 May;69(5):879-82. doi: 10.1136/ard.2009.113555. Epub 2009 Sep 22.

PMID:
19773289
4.

Corticosteroid injections in polymyalgia rheumatica: a double-blind, prospective, randomized, placebo controlled study.

Salvarani C, Cantini F, Olivieri I, Barozzi L, Macchioni L, Boiardi L, Niccoli L, Padula A, Pulsatelli L, Meliconi R.

J Rheumatol. 2000 Jun;27(6):1470-6.

PMID:
10852273
5.

EULAR response criteria for polymyalgia rheumatica: results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT).

Leeb BF, Bird HA, Nesher G, Andel I, Hueber W, Logar D, Montecucco CM, Rovensky J, Sautner J, Sonnenblick M.

Ann Rheum Dis. 2003 Dec;62(12):1189-94.

6.
7.

Baseline Shoulder Ultrasonography Is Not a Predictive Marker of Response to Glucocorticoids in Patients with Polymyalgia Rheumatica: A 12-month Followup Study.

Miceli MC, Zoli A, Peluso G, Bosello S, Gremese E, Ferraccioli G.

J Rheumatol. 2017 Feb;44(2):241-247. doi: 10.3899/jrheum.160090. Epub 2016 Dec 15.

PMID:
27980012
8.

Polymyalgia Rheumatica (PMR) Special Interest Group at OMERACT 11: outcomes of importance for patients with PMR.

Mackie SL, Arat S, da Silva J, Duarte C, Halliday S, Hughes R, Morris M, Pease CT, Sherman JW, Simon LS, Walsh M, Westhovens R, Zakout S, Kirwan JR.

J Rheumatol. 2014 Apr;41(4):819-23. doi: 10.3899/jrheum.131254. Epub 2014 Feb 1. Review.

PMID:
24488422
9.

Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica.

Gabriel SE, Sunku J, Salvarani C, O'Fallon WM, Hunder GG.

Arthritis Rheum. 1997 Oct;40(10):1873-8.

PMID:
9336424
10.

Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica.

Hutchings A, Hollywood J, Lamping DL, Pease CT, Chakravarty K, Silverman B, Choy EH, Scott DG, Hazleman BL, Bourke B, Gendi N, Dasgupta B.

Arthritis Rheum. 2007 Jun 15;57(5):803-9.

11.

Polymyalgia rheumatica: inflammation suppression with low dose of methylprednisolone or modified-release prednisone.

Benucci M, Olivito B, Manfredi M, Meacci F, Infantino M, Li Gobbi F, Sarzi-Puttini P, Marcassa C, Atzeni F.

Eur Rev Med Pharmacol Sci. 2015;19(5):745-51.

12.

Contribution of the polymyalgia rheumatica activity score to glucocorticoid dosage adjustment in everyday practice.

Cleuziou C, Binard A, De Bandt M, Berthelot JM, Saraux A.

J Rheumatol. 2012 Feb;39(2):310-3. doi: 10.3899/jrheum.110866. Epub 2011 Dec 15.

PMID:
22174199
13.

Corticosteroid requirements in polymyalgia rheumatica.

Weyand CM, Fulbright JW, Evans JM, Hunder GG, Goronzy JJ.

Arch Intern Med. 1999 Mar 22;159(6):577-84.

PMID:
10090114
14.

Polymyalgia rheumatica: clinical update.

Ameer F, McNeil J.

Aust Fam Physician. 2014 Jun;43(6):373-6. Review.

15.

[The support of the ultrasonography of the shoulder in the diagnosis of polymyalgia rheumatica with normal erythrocyte sedimentation rate].

Zaccaria A, Latinakis G, Oliveri M, Maio T, Frisone G, Versace F.

Reumatismo. 2009 Oct-Dec;61(4):290-7. Italian.

16.

Musculoskeletal ultrasound in the evaluation of Polymyalgia Rheumatica.

Iagnocco A, Finucci A, Ceccarelli F, Scirocco C, Rutigliano IM.

Med Ultrason. 2015 Sep;17(3):361-6. doi: 10.11152/mu.2013.2066.173.aig. Review.

17.

[Diagnostics and treatment of polymyalgia rheumatica].

Dejaco C, Matteson EL, Buttgereit F.

Z Rheumatol. 2016 Sep;75(7):687-700. doi: 10.1007/s00393-016-0105-3. Review. German.

PMID:
27488446
18.

[Rheumatic polymyalgia].

Calvo Romero JM, Ramos Salado JL, Pérez Miranda M.

An Med Interna. 2000 Jan;17(1):42-6. Spanish.

PMID:
10730406
19.

The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity.

Cimmino MA, Parodi M, Montecucco C, Caporali R.

BMC Musculoskelet Disord. 2011 May 14;12(1):94. doi: 10.1186/1471-2474-12-94.

20.

Diagnosis, differential diagnosis and treatment of polymyalgia rheumatica.

Nothnagl T, Leeb BF.

Drugs Aging. 2006;23(5):391-402. Review.

PMID:
16823992

Supplemental Content

Support Center